Supplemental financial information - Acquisition of Silicon Labs (Details) - USD ($) $ / shares in Units, $ in Millions |
3 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|
Feb. 04, 2026 |
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Business Combination, Contingent Consideration [Line Items] | |||||
| Acquisition charges | $ 7 | $ 0 | $ 41 | $ 0 | |
| Silicon Labs | |||||
| Business Combination, Contingent Consideration [Line Items] | |||||
| Acquire price her share (in dollars per share) | $ 231.00 | ||||
| Target company estimated enterprise value | $ 7,500 | ||||
| X | ||||||||||
- Definition Business Combination, Target Company Estimated Enterprise Value No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share price of saleable stock paid or offered to be paid by acquirer in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for acquisition-related cost incurred to effect business combination. Includes, but is not limited to, finder's fee; advisory, legal, accounting, valuation, and other professional and consulting fees; and general administrative cost, including cost of maintaining internal acquisition department. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|